Results 141 to 150 of about 118,577,238 (222)

Effects of Age and Birth Cohort on Influenza A Virus Subtype-Specific Hospitalization Rates, United States, 2010-2025. [PDF]

J Infect Dis
O'Halloran A, Hood N, Ujamaa D, Merced-Morales A, Gurbaxani B, Kirley PD, Napoles MJ, Alden NB, Aragon D, Meek J, Yousey-Hindes K, Openo KP, Witt LS, Monroe ML, Ryan PA, Leegwater L, Rojewski S, Kenyon C, Lynfield R, Poblete M, Landis ZQ, Anderson BJ, Rowe AJ, Felsen CB, Tesini BL, Harbi K, Wilson E, Lung K, Moran NE, Sutton M, Thomas A, Talbot HK, Schaffner W, Crossland M, Olsen K, Patel M, Fry AM, Kondor R, Bozio C, Reed C, Brammer L, Budd A, Flannery B, Garg S.   +43 more
europepmc   +1 more source

Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024-2026). [PDF]

IJID Reg
Aguilar-Luis MA, Valle-Mendoza JD, Tarazona-Castro Y, Aguilar-Luis D, de Villa EB, Cornejo-Tapia A, Antón A, Andrés C, Laguna-Torres A.   +8 more
europepmc   +1 more source

Influenza A(H3N2) Subclade K During the 2025-26 Season and Differential Humoral Responses in Vaccinated Individuals Versus Vaccinated Convalescents in Israel. [PDF]

Vaccines (Basel)
Nemet I, Zuckerman NS, Atari N, Kliker L, Jurkowicz M, Gilboa M, Weiss-Ottolenghi Y, Keller N, Stein M, Regev-Yochay G, Lustig Y, Mandelboim M.   +11 more
europepmc   +1 more source

Consensus H3N2 HA immunogens incorporating key antigenic mutations elicit broad-spectrum neutralizing responses. [PDF]

Emerg Microbes Infect
An Y, Cai M, Zhao C, Zhang M, Wu X, Huang W, Zhou X, Wang Y.   +7 more
europepmc   +1 more source

Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis

Journal of the Formosan Medical Association, 2017
Ku, Yee-Huang, Chuang, Yin-Ching, Yu, Wen-Liang   +2 more
openaire   +3 more sources

H3 Subtype Avian Influenza Virus: Ecology, Cross-Species Evolution, and Public Health Threats. [PDF]

Microorganisms
Cheng K, Yu Z.
europepmc   +1 more source

Characterisation of a human monoclonal antibody targeting a conserved epitope at the base of the HA head of influenza A(H3N2) virus. [PDF]

EBioMedicine
Yamayoshi S, Hamabata T, Inoue Y, Kiso M, Okuda M, Akasaka H, Shihoya W, Imamura T, Matsuzawa Y, Jubishi D, Iwatsuki-Horimoto K, Wilson PC, Nureki O, Kawaoka Y.   +13 more
europepmc   +1 more source

Exposure of dogs to influenza A and B viruses. [PDF]

One Health
Trombetta CM, Marotta MG, Marchi S, Bonfante F, Maniero S, Napolitan A, Moreno A, Chiapponi C, Temperton N, Scott S, Daly JM, Manenti A, Montomoli E, Lanave G, Camero M, Martella V.   +15 more
europepmc   +1 more source

Recurring Temporal Association Between Influenza A Epidemics and Subsequent Influenza B Dominance in Post-Pandemic Korea, 2022-2026. [PDF]

J Med Virol
Lee Y, Yoon Y, Park JE, Kim WK, Choi YY, Kim YK, Kang C, Yoo Y, Choe YJ.   +8 more
europepmc   +1 more source

Pulmonarom^® promotes TLR-related and interferon-related antiviral responses during influenza A (H1N1 and H3N2) infection in human monocyte-derived dendritic cells. [PDF]

Front Cell Infect Microbiol
Solano-Gálvez SG, Hernández-Aceves JA, García Lozano A, Wilkins-Rodríguez AA, Rojas Ortega DA, Ibarra A, Albores Méndez EM, Sciutto E, Gutiérrez-Kobeh L, Merchant Larios H, Cabello-Gutiérrez C, Fragoso G, Vázquez-López R.   +12 more
europepmc   +1 more source